ARDX: Ardelyx, Inc.
Performance
ARDX -47.58%
Watchlist
Select an item
Summary
ARDX at a glance
ARDX returned -47.59% over the past year and +19.49% a year over five years. Its worst drop in that year was -63.95%, smaller than 10% of stocks on Redstone, and its Sharpe ratio of -0.88 beats 5% of stocks on Redstone. It pays no dividends.
Current Drawdown
-63.33%
Rolling Volatility
58.75%
Actions
Metrics
Risk Indicators
Alpha-60.55%
Beta0.93x
Sharpe-0.88
Sortino-1.27
Omega0.84
Calmar-0.74
Martin-1.48
Profile
About ARDX
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $737M
- Listed
- Jun 2014
- Employees
- 489
- Headquarters
- Fremont, CA
- Website
- ardelyx.com
Comparisons